Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium-Reference-Cited by-同舟云学术

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium

Published:2020-01 Issue:1 Volume:16 Page:106-117
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's Dement.

Author:

Miyagawa Toji¹,Brushaber Danielle¹,Syrjanen Jeremy¹,Kremers Walter¹,Fields Julie¹,Forsberg Leah K.¹,Heuer Hilary W.²,Knopman David¹,Kornak John²,Boxer Adam²,Rosen Howard J.²,Boeve Bradley F.¹,Appleby Brian³,Bordelon Yvette⁴,Bove Jessica⁵,Brannelly Patrick⁶,Caso Christina⁷,Coppola Giovanni⁴,Dever Reilly²,Dheel Christina¹,Dickerson Bradford⁸,Dickinson Susan⁹,Dominguez Sophia⁵,Domoto-Reilly Kimiko⁷,Faber Kelley¹⁰,Ferrell Jessica¹¹,Fishman Ann¹²,Fong Jamie²,Foroud Tatiana¹⁰,Gavrilova Ralitza¹,Gearhart Debra¹,Ghazanfari Behnaz¹³,Ghoshal Nupur¹⁴,Goldman Jill S.¹⁵,Graff-Radford Jonathan¹,Graff-Radford Neill¹⁶,Grant Ian¹⁷,Grossman Murray⁵,Haley Dana¹⁶,Hsiung Robin¹⁸,Huey Edward¹⁵,Irwin David⁵,Jones David¹,Jones Lynne¹⁴,Kantarci Kejal¹,Karydas Anna²,Kaufer Daniel¹¹,Kerwin Diana¹⁹,Kraft Ruth¹,Kramer Joel²,Kukull Walter²⁰,Litvan Irene²¹,Lucente Diane⁸,Lungu Codrin²²,Mackenzie Ian¹⁸,Maldonado Miranda⁴,Manoochehri Masood¹⁵,McGinnis Scott⁸,McKinley Emily²³,Mendez Mario F.⁴,Miller Bruce²,Multani Namita¹³,Onyike Chiadi¹²,Padmanabhan Jaya⁸,Pantelyat Alexander¹²,Pearlman Rodney²⁴,Petrucelli Leonard¹⁶,Potter Madeline¹⁰,Rademakers Rosa¹⁶,Ramos Eliana M.⁴,Rankin Kate²,Rascovsky Katya⁵,Roberson Erik D.²³,Rogalski Emily¹⁷,Sengdy Pheth¹⁸,Shaw Leslie⁵,Tartaglia Maria C.¹⁰,Tatton Nadine⁹,Taylor Joanne²,Toga Arthur²⁵,Trojanowski John Q.⁵,Wang Ping²,Weintraub Sandra¹⁷,Wong Bonnie⁸,Wszolek Zbigniew¹⁶

Affiliation:

1. Mayo Clinic; Rochester Minnesota USA

2. University of California San Francisco; San Francisco California USA

3. Case Western Reserve University; Cleveland Ohio USA

4. University of California Los Angeles; Los Angeles California USA

5. University of Pennsylvania; Philadelphia Pennsylvania USA

6. Tau Consortium; Rainwater Charitable Foundation; Fort Worth Texas USA

7. University of Washington; Seattle Washington USA

8. Harvard University/Massachusetts General Hospital; Boston Massachusetts USA

9. Association for Frontotemporal Degeneration; Radnor Pennsylvania USA

10. National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD); Indiana University; Indianapolis Indiana USA

11. University of North Carolina; Chapel Hill North Carolina USA

12. Johns Hopkins University; Baltimore Maryland USA

13. University of Toronto; Toronto Ontario Canada

14. Washington University; St. Louis Missouri USA

15. Columbia University; New York New York USA

16. Mayo Clinic; Jacksonville Florida USA

17. Northwestern University; Chicago Illinois USA

18. University of British Columbia; Vancouver British Columbia Canada

19. University of Texas Southwestern; Dallas Texas USA

20. National Alzheimer Coordinating Center (NACC); University of Washington; Seattle Washington USA

21. University of California San Diego; San Diego California USA

22. National Institute of Neurological Disorders and Stroke (NINDS); Bethesda Maryland USA

23. University of Alabama; Birmingham Alabama USA

24. Bluefield Project; San Francisco California USA

25. Laboratory of Neuroimaging (LONI); University of Southern California; Los Angeles California USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/alz.12033/fullpdf

Reference24 articles.

1. A new clinical scale for the staging of dementia;Hughes;Br J Psychiatry,1982

2. The clinical dementia rating (CDR): current version and scoring rules;Morris;Neurology,1993

3. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration;Knopman;Brain,2008

4. Language and behavior domains enhance the value of the clinical dementia rating scale;Knopman;Alzheimers Dement,2011

5. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study;Schneider;Alzheimer Dis Assoc Disord.,1997

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Better cardiovascular health is associated with slowed clinical progression in autosomal dominant frontotemporal lobar degeneration variant carriers;Alzheimer's & Dementia;2024-09-06

2. Cognitive dispersion and its functional relevance in behavioral variant frontotemporal dementia and prodromal behavioral variant frontotemporal dementia.;Neuropsychology;2024-08-29

3. Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia;2024-08-20

4. CSF Proteomics in Patients With Progressive Supranuclear Palsy;Neurology;2024-08-13

5. Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration;The American Journal of Geriatric Psychiatry;2024-08